Latest Period
Q2 2026
Security Snapshot
ADIAL PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (ADIL) Institutional Ownership
CUSIP: 00688A304
13F Institutional Holders and Ownership History from Q1 2026 to Q2 2026
Institutions Reporting
17
Shares (Excl. Options)
136,451
Price
$2.56
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- ADIL on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 136,451
- Total 13F value
- $334,555
- Portfolio coverage rank
- 0%
- Share change
- +100,822
- Value change
- +$243,362
- Number of holders
- 17
- Shares outstanding
- 2,625,331
- SEC-reported price per share
- $3.29
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ADIL - ADIAL PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share is tracked under CUSIP 00688A304.
- 17 institutions reported positions in Q2 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 17 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $63,776 to $334,555.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 17 institutions filings for Q2 2026.
Security key
00688A304
Latest holder period
Q2 2026
13F holders
17
13D/G owners
1
CIK / CUSIP context first
Open Q2 2026 holders
ADIL full holder history
ADIAL PHARMACEUTICALS, INC. SEC filings
ADIAL PHARMACEUTICALS, INC. company facts
ADIAL PHARMACEUTICALS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00688A304:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
ADIL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Coastlands Capital LP | 14% | +42% | $1,112,500 | +$331,242 | 373,322 | +42% | Coastlands Capital LP | 24 Jun 2026 |
As of 30 Jun 2026, 17 institutional investors reported holding 136,451 shares of ADIAL PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (ADIL). This represents 5.2% of the company’s total 2,625,331 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q2 2026
Rows shown
1-2 of 2